罗哌卡因激活促凋亡与炎症信号通路或触发硬膜外相关产热
本研究以人脐静脉内皮细胞(HUVEC)和胎盘滋养层细胞(TB)为模型,探讨罗哌卡因的分子效应并与利多卡因和地塞米松比较。罗哌卡因剂量依赖性诱导凋亡及IL-6、IL-8、PGE2释放,激活caspase-3、NF-κB和p38 MAPK通路,地塞米松仅部分减轻其损伤效应。
要点
- 罗哌卡因剂量依赖性诱导HUVEC和TB凋亡并释放IL-6、IL-8、PGE2。
- 罗哌卡因激活caspase-3、NF-κB、p38 MAPK通路,抑制ERK1/2和Akt。
- 地塞米松仅部分减轻罗哌卡因损伤,且长期可能损害线粒体功能。
核心结论
- 罗哌卡因通过不同信号通路导致HUVEC和TB细胞损伤与死亡,地塞米松仅部分减轻其有害效应,提示炎症在硬膜外相关产热中具有重要作用。
研究设计与样本
- 体外细胞实验,以人脐静脉内皮细胞(HUVEC)和人胎盘滋养层细胞(TB)为模型。
- HUVEC和TB暴露于罗哌卡因(35 μM-7 mM)或利多卡因(21 mM),联合或不联合地塞米松(1 μM)。
主要发现
- 罗哌卡因剂量依赖性诱导凋亡,并增加HUVEC和TB释放IL-6、IL-8和PGE2。
- 罗哌卡因激活caspase-3、NF-κB和p38 MAPK通路,使ERK1/2和Akt去磷酸化。
- 罗哌卡因下调抗氧化蛋白诱导氧化应激,上调ICAM1、VCAM1和PECAM1可能促进白细胞迁移。
- 罗哌卡因增加促炎性线粒体DNA损伤相关分子模式释放,但线粒体膜电位无显著耗散。
- 利多卡因在所有时间点抑制IL-6和IL-8释放,早期下调COX2和细胞黏附分子,随后出现晚期过度反应。
关键数值与推荐
- 罗哌卡因浓度范围为35 μM-7 mM,利多卡因浓度为21 mM,地塞米松浓度为1 μM。
临床怎么用
- 提示罗哌卡因可能通过促炎和促凋亡机制参与硬膜外相关产热,临床需关注其炎症效应。
- 地塞米松可部分减轻罗哌卡因炎症效应,但长期使用可能对线粒体功能有负面影响。
局限性
- 研究为体外细胞实验,结果不能直接推断至人体临床。
- 罗哌卡因浓度范围较宽,部分浓度可能超出临床血药浓度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Epidural-related maternal fever (ERMF) is an adverse effect of epidural analgesia during labor and is associated with perinatal and neonatal morbidity. Local anesthetics have been proposed to trigger ERMF via sterile inflammation. Ropivacaine is currently the most frequently used epidural anesthetic and considered least toxic. This study investigates molecular effects of ropivacaine on human umbilical vein endothelial cells (HUVECs) as model system for endothelial cells and human placental trophoblasts (TBs), compares the effects to the putative anti-inflammatory lidocaine and investigates the partially alleviating impact of the anti-inflammatory corticosteroid dexamethasone. METHODS: HUVECs and TBs were exposed to ropivacaine (35 μM-7 mM) or lidocaine (21 mM) with or without dexamethasone (1 μM). AnnexinV/propidium iodide staining and lactate dehydrogenase release were used to analyze apoptosis and cytotoxicity. Proinflammatory interleukins-6 (IL-6) and IL-8 as well as prostaglandin E2 (PGE2) were measured by enzyme-linked immunosorbent assay (ELISA), while activation of signaling pathways was detected by Western blotting. Oxidative stress was visualized by live cell imaging and quantification of antioxidant proteins, intercellular adhesion molecule 1, vascular cell adhesion molecule 1, platelet endothelial cell adhesion molecule 1, cyclooxygenase 2, and mitochondrial deoxyribonucleic acid by real-time polymerase chain reaction. Dissipation of the mitochondrial membrane potential was assessed with cytofluorimetric analysis using the J-Aggregate (JC-1 staining [cytofluorimetric analysis using the J-Aggregate]). RESULTS: Ropivacaine exposure dose-dependently induced apoptosis and an increased release of IL-6, IL-8, and PGE2 from HUVECs and TBs. Furthermore, caspase-3, nuclear factor-κB, and p38 mitogen-activated protein kinase pathways were activated, while extracellular signal-regulated kinase 1/2 and protein kinase B (Akt) were dephosphorylated. Downregulation of antioxidative proteins induced oxidative stress and upregulation of ICAM1, VCAM1, and PECAM1 possibly facilitate leukocyte transmigration. Mitochondrial effects included increased release of the proinflammatory mitochondrial DNA damage-associated molecular patterns, but no significant dissipation of the mitochondrial membrane potential. Conversely, lidocaine exhibited repression of IL-6 and IL-8 release over all time points, and early downregulation of COX2 and cell adhesion molecules, which was followed by a late overshooting reaction. Dexamethasone reduced especially inflammatory effects, but as an inducer of mitophagy, had negative long-term effects on mitochondrial function. CONCLUSIONS: This study suggests that ropivacaine causes cellular injury and death in HUVECs and TBs via different signaling pathways. The detrimental effects induced by ropivacaine are only partially blunted by dexamethasone. This observation strengthens the importance of inflammation in ERMF.
引用
- Wohlrab P, Boehme S, Kaun C, et al. Ropivacaine Activates Multiple Proapoptotic and Inflammatory Signaling Pathways That Might Subsume to Trigger Epidural-Related Maternal Fever. Anesth Analg. 2020. PMID: 31498191. doi:10.1213/ANE.0000000000004402
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。